|Bid||25.44 x 1200|
|Ask||26.79 x 1300|
|Day's Range||24.68 - 25.83|
|52 Week Range||5.51 - 26.14|
|Beta (5Y Monthly)||0.93|
|PE Ratio (TTM)||50.92|
|Earnings Date||Aug 07, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Feb 01, 2019|
|1y Target Est||26.50|
Meridian Bioscience (VIVO) closed at $24.49 in the latest trading session, marking a -1.84% move from the prior day.
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]